CD36 and neoplasm: CD36 inhibition using either anti-CD36 monoclonal antibodies (mAbs) or oleic acid analog sulfo-n-succinimidyl oleate (SSO), which irreversibly binds CD36, have proven efficacy in preventing tumor growth and metastasis in preclinical models [71,76,77,78].